Determinants of Response to Sequential Pembrolizumab with Trastuzumab Plus Platinum/5-FU in HER2-Positive Gastric Cancer: A Phase II Chemoimmunotherapy Trial.
Clinical cancer research an official journal of the American Association for Cancer Research（2025）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要